| Male Reproductive System Carcinoma studied in …STUDIED_INderived200 of 1,217show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541210NA · recruiting Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07185165Phase 2 · recruiting An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06031805active not recruiting PRostate Olaparib Real World Evidence Study · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472817enrolling by invitation Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594106Phase 1/Phase 2 · recruiting REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123758Phase 1 · active not recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460977Phase 1 · recruiting A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568656Phase 1/Phase 2 · completed Study to Evaluate CCS1477 in Advanced Tumours · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071236Phase 1/Phase 2 · suspended Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136650Phase 3 · recruiting A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629779Phase 3 · recruiting A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06801236Phase 1 · recruiting Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07126548NA · recruiting A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07377006NA · recruiting Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085043NA · active not recruiting Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05241860Phase 2 · active not recruiting Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06052306Phase 1 · active not recruiting A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06836726Phase 2 · not yet recruiting Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07719361Phase 1 · recruiting A Study in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025369Phase 2 · recruiting Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894511Phase 2 · active not recruiting An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570979Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824349Phase 1 · recruiting JUR-003 in Adult Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104893Phase 2 · active not recruiting A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615845Phase 1 · terminated A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521412Phase 1/Phase 2 · recruiting EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053842Phase 2 · completed Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985565NA · active not recruiting Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365995Phase 3 · recruiting A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003752Phase 1/Phase 2 · active not recruiting Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05011188Phase 1/Phase 2 · active not recruiting FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616650Phase 2 · recruiting Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665738NA · recruiting Two-fraction HDR Monotherapy for Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813637Phase 1 · recruiting Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06380738active not recruiting Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07549256Phase 2 · recruiting Cannabidiol for Pain Relief of Patients With End-stage mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07608718Phase 2 · not yet recruiting Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02522715Phase 1/Phase 2 · active not recruiting Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03697148NA · active not recruiting Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04286386withdrawn Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05670106Phase 2 · completed A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493512Phase 1 · recruiting Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581184Phase 1 · recruiting A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808359Phase 2 · not yet recruiting Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807065Phase 2 · completed Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04905082NA · active not recruiting HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940271NA · recruiting Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07075705NA · recruiting Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815197Phase 2 · not yet recruiting Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05762536Phase 2 · recruiting Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05766371Phase 2 · recruiting Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946213Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06040125NA · recruiting Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06100705Phase 2 · recruiting Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317392Phase 1/Phase 2 · active not recruiting Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04592237Phase 2 · active not recruiting Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Aggressive Variant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035500NA · active not recruiting Long-Term Follow-Up in Patients With Prostate Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05502315Phase 2 · active not recruiting Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067295recruiting Longitudinal Advanced Prostate Cancer Cohort (LAPCC) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764485Phase 3 · active not recruiting A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04597359Phase 2 · active not recruiting To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803653Phase 1 · not yet recruiting IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470750completed Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06909825Phase 2 · active not recruiting FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005154Phase 2 · recruiting A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285694Phase 1/Phase 2 · active not recruiting AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287150Phase 2 · recruiting A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07545811Phase 1 · recruiting Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723248Phase 3 · recruiting A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762759Phase 2 · active not recruiting Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632977Phase 2 · recruiting Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931340Phase 3 · recruiting Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200830Phase 3 · recruiting Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07609225early Phase 1 · not yet recruiting Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710380NA · recruiting MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162194NA · recruiting MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07798778early Phase 1 · recruiting Clinical Evaluation of SRT-017 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305654Phase 3 · active not recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma, Usual Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726292Phase 2 · recruiting A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654336Phase 2 · recruiting Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466498Phase 2 · not yet recruiting Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Sensitive Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371719Phase 2 · active not recruiting Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05171816Phase 3 · active not recruiting Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982222Phase 1 · withdrawn Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07054346Phase 1 · recruiting Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218666Phase 2 · recruiting Zanzalintinib in Men With Aggressive Variant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Aggressive Variant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07790718NA · recruiting Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698535Phase 2 · recruiting Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204123Phase 2 · active not recruiting PSMA PET Imaging of Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442556Phase 2 · terminated Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090528Phase 2 · active not recruiting pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04631601Phase 1/Phase 2 · terminated Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611110Phase 3 · recruiting AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022822Phase 2 · recruiting Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06024772Phase 3 · not yet recruiting Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019327Phase 1/Phase 2 · terminated A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07745361Phase 2 · recruiting Study of Oral MRT-2359 With Apalutamide in Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805371Phase 1 · recruiting PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06844383Phase 2 · recruiting A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04457232Phase 1 · active not recruiting Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945642NA · recruiting High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200103Phase 2 · suspended Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06785636Phase 1/Phase 2 · recruiting A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995053NA · active not recruiting Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644598Phase 2 · recruiting MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104776Phase 1/Phase 2 · recruiting A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550494Phase 2 · active not recruiting Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03732820Phase 3 · active not recruiting Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06966024Phase 1 · recruiting Study of DCC-2812 in Participants With Advanced Genitourinary Cancers · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134260Phase 3 · active not recruiting Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053152Phase 2 · active not recruiting Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919264Phase 1/Phase 2 · recruiting FOG-001 in Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06535802completed iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06842498Phase 2 · recruiting A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957691Phase 2 · recruiting Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07202247Phase 2 · recruiting Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767266Phase 2 · not yet recruiting Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953640completed Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04789018completed Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235151Phase 3 · active not recruiting Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06717711Phase 3 · recruiting Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218718NA · completed Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766486NA · active not recruiting Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03624660Phase 2 · active not recruiting Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05519449Phase 1 · recruiting Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05722288Phase 2 · active not recruiting Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126070Phase 2 · active not recruiting Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04489719recruiting Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613894Phase 1 · recruiting Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236139Phase 1/Phase 2 · recruiting Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257693Phase 1 · recruiting Enzalutamide Implants (Enolen) in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02949284Phase 2 · active not recruiting Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04519879Phase 2 · suspended White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832086Phase 2 · recruiting Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067841Phase 1 · recruiting A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305598Phase 1 · active not recruiting Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038369Phase 1 · active not recruiting A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01050504recruiting Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419234Phase 2 · active not recruiting Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610852NA · recruiting Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06145633Phase 2 · recruiting Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455903Phase 2 · recruiting Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04030338active not recruiting Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07364071Phase 2 · recruiting Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03152786Phase 2 · terminated Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04646434NA · suspended Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893917Phase 2 · active not recruiting Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma with Neuroendocrine Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517969Phase 2 · active not recruiting M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Penile Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05828082Phase 2 · active not recruiting Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879940Phase 2 · active not recruiting Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751434Phase 2 · recruiting A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325046NA · recruiting Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288359Phase 1/Phase 2 · recruiting Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246347Phase 2 · active not recruiting A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04484818Phase 3 · active not recruiting Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07096999recruiting SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002540NA · active not recruiting Screening for Prostate Cancer in Older Patients (PLCO Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03456843Phase 2 · active not recruiting Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113537Phase 1/Phase 2 · recruiting Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228404early Phase 1 · active not recruiting Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06238713NA · recruiting Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06895811Phase 1 · active not recruiting Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06942104Phase 1 · recruiting Imaging of Solid Tumors Using 18F-TRX · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052214Phase 3 · recruiting PSMA PET Combined With MRI for the Detection of PCa · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641855Phase 2/Phase 3 · not yet recruiting A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352429active not recruiting Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03796767Phase 2 · completed Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438563NA · recruiting MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05689021Phase 2 · terminated CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04254133enrolling by invitation Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04549207Phase 4 · active not recruiting Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer · condition mapped ALIAS · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039371Phase 2 · recruiting Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520345Phase 3 · recruiting The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) · condition mapped CURATED_BROADER · 1,217 trials mapped (494 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743934Phase 2 · completed Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 1,217 trials mapped (494 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |